The global biopharmaceutical third party logistics market size is expected to reach around US$ 159.86 billion by 2030 from US$ 100.23 billion in 2021 and is expected to grow at an impressive double-digit rate of 5.3% from 2022 to 2030.
The burgeoning demand for the biopharmaceutical drugs across the developed and developing nations is a prominent factor that boosts the growth of the global biopharmaceutical third party logistics market.
The study includes drivers and restraints of this market. The study provides an analysis of the global biopharmaceutical third party logistics market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1540
Why should you invest in this report?
If you are aiming to enter the global biopharmaceutical third party logistics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for biopharmaceutical third party logistics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global biopharmaceutical third party logistics market include:
- Agility Logistics
- AmerisourceBergen Corporation
- DB Schenker
- DHL International GmbH
- FedEx Corporation
- Kerry Logistics Network Limited
- Kuehne + Nagel International AG
- McKesson Corporation
- SF Express Co. Ltd.
- United Parcel Service of America, Inc.
Market Segmentation:
By Service Type
- Warehousing & Storage
- Transportation
- Sea Freight
- Overland
- Air Freight
- Others
By Supply Chain
- Cold Chain
- Non-Cold Chain
Regional Analysis:
The geographical analysis of the global biopharmaceutical third party logistics market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global biopharmaceutical third party logistics Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global biopharmaceutical third party logistics market in 2030?
- What is the expected CAGR for the biopharmaceutical third party logistics market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global biopharmaceutical third party logistics market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biopharmaceutical Third Party Logistics Market
5.1. COVID-19 Landscape: Biopharmaceutical Third Party Logistics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biopharmaceutical Third Party Logistics Market, By Service
8.1. Biopharmaceutical Third Party Logistics Market, by Service Type, 2022-2030
8.1.1. Warehousing & Storage
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Transportation
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Biopharmaceutical Third Party Logistics Market, By Supply Chain
9.1. Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2022-2030
9.1.1. Cold Chain
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Non-Cold Chain
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Biopharmaceutical Third Party Logistics Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Service (2019-2030)
10.1.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Service (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Service (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Service (2019-2030)
10.2.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Service (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Service (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Service (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Service (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Service (2019-2030)
10.3.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Service (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Service (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Service (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Service (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Service (2019-2030)
10.4.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Service (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Service (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Service (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Service (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Service (2019-2030)
10.5.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Service (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Service (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Supply Chain (2019-2030)
Chapter 11. Company Profiles
11.1. Agility Logistics
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. AmerisourceBergen Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. DB Schenker
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. DHL International GmbH
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. FedEx Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Kerry Logistics Network Limited
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Kuehne + Nagel International AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. McKesson Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. SF Express Co. Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. United Parcel Service of America, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1540
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments